Beyond Meat Stock Drops After Another Weak Quarter
Beyond Meat missed earnings, stock fell 9%. Sales weak, losses high, but costs improved. Demand for plant meat still low.
Already have an account? Sign in.
Beyond Meat missed earnings, stock fell 9%. Sales weak, losses high, but costs improved. Demand for plant meat still low.
Supermicro announced a $7 billion equity and equity-linked offering to fund $39 billion in new AI server orders from over 20 customers.
Cellectis got FDA RMAT for lasme-cel, an off-the-shelf CAR-T therapy for hard-to-treat leukemia that may speed up patient access.
Cracker Barrel beat expectations, raised outlook, and saw shares jump as turnaround efforts and strong execution boost confidence.